Svend O Freytag

Title: Svend O Freytag: Innovator in Cancer Therapy

Introduction

Svend O Freytag is a notable inventor based in West Bloomfield, MI (US). He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on utilizing novel adenoviruses to combat cancer effectively.

Latest Patents

Freytag holds a patent for "Methods and compositions for cancer therapy using a novel adenovirus." This invention comprises a unique virus capable of efficiently killing mammalian cancer cells. The virus produces a novel protein that converts two non-toxic prodrugs into potent chemotherapeutic agents. These agents are produced locally, aiding the virus in killing cancer cells and sensitizing them to radiation. In preclinical studies, the virus has demonstrated effectiveness in eliminating various mammalian cancer cells, either alone or in combination with prodrug therapy and/or radiation therapy. This invention may offer a safe and effective treatment option for human cancer.

Career Highlights

Freytag is affiliated with the Henry Ford Health System, where he continues to advance his research in cancer therapy. His dedication to improving treatment options for cancer patients is evident in his innovative approach to utilizing viral therapies.

Collaborations

Freytag has collaborated with esteemed colleagues, including Jae Ho Kim and Ken Barton, to further enhance the impact of his research in the medical field.

Conclusion

Svend O Freytag's contributions to cancer therapy through his innovative patent highlight his commitment to advancing medical science. His work may pave the way for safer and more effective cancer treatments in the future.